investigational - Robuta Search

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/factors-consider-when-making-benefit-risk-determinations-medical-device-investigational-device Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational... The purpose of this guidance is to provide greater clarity for FDA staff and investigational device exemption (IDE) sponsors and sponsor-investigators1... factors to consider benefit risk https://www.businesswire.com/news/home/20230308005894/en/Vertex-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-VX-264-a-Novel-Encapsulated-Cell-Therapy-for-the-Treatment-of-Type-1-Diabetes?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264, a Novel... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug ... https://www.merck.com/news/moderna-and-merck-announce-mrna-4157-v940-an-investigational-personalized-mrna-cancer-vaccine-in-combination-with-keytruda-pembrolizumab-met-primary-efficacy-endpoint-in-phase-2b-keynote-94/ Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in... Apr 17, 2026 - mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a statistically significant and clinically meaningful reduction in the risk of disease recurrence or... mrna 4157 v940 https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-first-phase-ii-hiv-prevention-study-results-for-investigational-long-acting-injectable-cabotegravir/ ViiV Healthcare announces first phase II HIV prevention study results for investigational... Results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. viiv healthcare first phase https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-06240 An Investigational Scan (89Zr-DFO-Girentuximab PET/CT) for Determining the Treatment Effects of... An Investigational Scan (89Zr-DFO-Girentuximab PET/CT) for Determining the Treatment Effects of Belzutifan in Patients with Advanced Clear Cell Renal Cell... https://www.uhhospitals.org/uh-research/find-clinical-trials-and-studies/clinical-trials-search/cystic-fibrosis-exacerbation-investigational-antibiotic-study-16250 Cystic Fibrosis Exacerbation Investigational Antibiotic Study * | University Hospitals Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360) cystic fibrosis exacerbation investigational antibiotic study https://www.newswire.ca/news-releases/essa-pharma-inc-announces-filing-of-investigational-new-drug-application-for-epi-506-517415241.html ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has filed with the Food and Drug Administration ("FDA") in the US an... investigational new drug https://www.biospace.com/bristol-myers-squibb-release-study-of-next-generation-investigational-hiv-1-maturation-inhibitor-shows-positive-results-in-preventing-viral-replicati Bristol-Myers Squibb Release: Study Of Next-Generation Investigational HIV-1 Maturation Inhibitor... bristol myers squibb https://wellcomecollection.org/concepts/sb6hrc8j Investigational New Drug Application | Wellcome Collection Find books, manuscripts, paintings, illustrations, photos and unpublished archives about Investigational New Drug Application, many of them with free online... investigational new drug application wellcome collection https://www.sciencedaily.com/releases/2015/03/150302182056.htm Investigational therapy could attack cause of sickle cell crises | ScienceDaily Treatment for painful episodes of blood vessel obstruction in sickle cell anemia is currently limited to controlling pain, but an investigational therapy might... investigational therapy sickle cell could attack cause https://www.jnj.com/innovativemedicine/emea/newsroom/immunology/new-data-shows-jnj-2113-the-first-and-only-investigational-targeted-oral-peptide-maintained-skin-clearance-in-moderate-to-severe-plaque-psoriasis-through-one-year New data shows JNJ-2113, the first and only investigational targeted oral peptide, maintained skin... Sep 26, 2025 - JNJ-2113 long-term extension FRONTIER 2 study demonstrated sustained efficacy from Week 16 to Week 52 and safety results consistent with previously reported... https://www.merck.com/news/merck-provides-update-on-phase-3-keyform-007-trial-evaluating-investigational-fixed-dose-combination-of-favezelimab-and-pembrolizumab-for-patients-with-previously-treated-pd-l1-positive-microsatellite/ Merck Provides Update on Phase 3 KEYFORM-007 Trial Evaluating Investigational Fixed-Dose... Dec 31, 2025 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYFORM-007 trial evaluating the investigational... https://www.merck.com/news/merck-and-pfizer-announce-that-investigational-sglt-2-inhibitor-ertugliflozin-met-primary-endpoint-in-two-phase-3-studies/ Merck and Pfizer Announce That Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint... May 11, 2026 - Ertugliflozin as Add-on to Metformin or in Initial Co-administration with Sitagliptin Showed Significant A1C Reductions in Adults with Type 2 Diabetes... sglt 2 inhibitor https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application?ref=limestonepost.org Investigational New Drug (IND) Application | FDA Get to know the investigational new drug application (IND). This includes the types, laws and regulations, and emergency use of INDs. investigational new drug ind application fda https://www.pfizer.com/news/press-release/press-release-detail/pfizer_doses_first_patient_using_investigational_mini_dystrophin_gene_therapy_for_the_treatment_of_duchenne_muscular_dystrophy Pfizer Doses First Patient Using Investigational Mini-Dystrophin Gene Therapy for the Treatment of... Pfizer Inc. has initiated a Phase 1b clinical trial for its mini-dystrophin gene therapy candidate, PF-06939926, in boys with Duchenne muscular dystrophy (DMD). https://www.biospace.com/forge-biologics-announces-fda-clearance-of-investigational-new-drug-application-for-phase-1-2-clinical-trial-reskue-of-fbx-101-gene-therapy-for-patients-with-krabbe-disease Forge Biologics Announces FDA Clearance of Investigational New Drug Application for Phase 1/2... Jan 4, 2021 - Forge Biologics Inc., a gene therapy manufacturing and development company, today announced that the company has received FDA clearance of the Investigational... https://www.gilead.com/news/news-details/2017/gilead-presents-results-from-phase-3-study-evaluating-patients-who-switched-to-investigational-fixed-dose-combination-of-bictegravir-emtricitabine-and-tenofovir-alafenamide-from-boosted-prot Gilead Presents Results From Phase 3 Study Evaluating Patients Who Switched to Investigational... Gilead Presents Results From Phase 3 Study Evaluating Patients Who Switched to Investigational Fixed Dose Combination of Bictegravir Emtricitabine and... phase 3 study https://investingnews.com/investigational-lenacapavir-receives-positive-chmp-opinion-for-people-with-multi-drug-resistant-hiv/ Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV... Jun 24, 2022 - Recommendation is Based on Week 26 Data from the CAPELLA Trial Showing Twice-Yearly Lenacapavir Achieved High Rates of Virologic Suppression in Heavily... https://www.cancer.gov/publications/dictionaries/cancer-terms/def/investigational-drug Definition of investigational drug - NCI Dictionary of Cancer Terms - NCI NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. definition of investigational drug nci dictionary cancer https://www.businesswire.com/news/home/20201001005382/en/Pfizer-Receives-FDA-Fast-Track-Designation-for-Duchenne-Muscular-Dystrophy-Investigational-Gene-Therapy Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene... Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (D... fda fast track duchenne muscular dystrophy https://investingnews.com/news/biotech-investing/amgen-licenses-amg-634-an-investigational-treatment-for-tuberculosis-and-leprosy-to-medicines-development-for-global-health/ Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines... Mar 8, 2022 - - Amgen (NASDAQ:AMGN) and Medicines Development for Global Health (MDGH), a non-profit biopharmaceutical company, today announced that the companies have... https://www.prnewswire.com/news-releases/alkermes-to-present-two-posters-on-investigational-immuno-oncology-candidate-nemvaleukin-alfa-at-the-2021-european-society-for-medical-oncology-esmo-virtual-congress-301374881.html Alkermes to Present Two Posters on Investigational Immuno-oncology Candidate, Nemvaleukin Alfa, at... /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced two poster presentations related to nemvaleukin alfa (nemvaleukin), the company's novel,... https://investingnews.com/abbvie-to-acquire-gilgamesh-pharmaceuticals-bretisilocin-a-novel-investigational-therapy-for-major-depressive-disorder-expanding-psychiatry-pipeline/ AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for... Aug 25, 2025 - Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major... to acquire gilgamesh pharmaceuticals investigational therapy abbvie https://www.businesswire.com/news/home/20230911947101/en/Heartseed-Announces-the-Presentation-of-HS-001-an-Investigational-Stem-Cell-Derived-Therapy-for-the-Treatment-of-Advanced-Heart-Failure-at-the-71st-Annual-Meeting-of-the-Japanese-College-of-Cardiology Heartseed Announces the Presentation of HS-001, an Investigational Stem Cell-Derived Therapy for... Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure, today announced that the case repor... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01629 A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That... A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer https://www.tampabay28.com/news/health/darlene-gant-gets-investigational-drug-to-fight-off-breast-cancer Dying mom tries investigational drug Oct 1, 2015 - DarleneGant knew she was dying and made a YouTube appeal for the use of an investigational drug. dying mom tries investigational drug https://www.businesswire.com/news/home/20250507731762/en/UroGen-Announces-FDA-Advisory-Committee-for-UGN-102-an-Investigational-Treatment-for-Recurrent-Low-Grade-Intermediate-Risk-Non-Muscle-Invasive-Bladder-Cancer UroGen Announces FDA Advisory Committee for UGN-102, an Investigational Treatment for Recurrent... UroGen (NASDAQ: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today ... advisory committee https://www.gilead.com/news/news-details/2001/gilead-sciences-announces-data-from-studies-of-adefovir-dipivoxil-investigational-agent-for-the-treatment-of-chronic-hepatitis-b-infection Gilead Sciences Announces Data from Studies of Adefovir Dipivoxil, Investigational Agent for the... Gilead Sciences Announces Data from Studies of Adefovir Dipivoxil Investigational Agent for the Treatment of Chronic Hepatitis B Infection https://www.merck.com/news/merck-announces-positive-data-for-v116-an-investigational-21-valent-pneumococcal-conjugate-vaccine-specifically-designed-for-adults/ Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate... Dec 31, 2025 - Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases Results build on... positive data https://www.biospace.com/the-medicines-company-advances-clinical-development-of-investigational-first-in-class-pcsk9-synthesis-inhibitor-for-atherosclerotic-cardiovascular-dis The Medicines Company Advances Clinical Development Of Investigational First-In-Class PCSK9... first in class clinical development https://investingnews.com/news/market-news/merck-provides-update-on-phase-2-clinical-trial-of-once-weekly-investigational-combination-of-mk-8507-and-islatravir-for-the-treatment-of-people-living-with-hiv-1/ Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of... Mar 19, 2024 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced an update regarding the Phase 2 IMAGINE-DR clinical trial (MK-8507-13),... phase 2 clinical trial https://www.prnewswire.com/news-releases/new-data-on-bayers-investigational-hemophilia-a-compound-bay-81-8973-in-previously-treated-children-published-in-haemophilia-300191257.html New Data on Bayer's Investigational Hemophilia A Compound, BAY 81-8973, in Previously Treated... /PRNewswire/ -- New Phase III data from Bayer's LEOPOLD Kids clinical trial investigating the safety and efficacy of BAY 81-8973 in previously treated... https://www.fda.gov/regulatory-information/search-fda-guidance-documents/chemistry-manufacturing-and-control-cmc-information-human-gene-therapy-investigational-new-drug Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New... This is the Guidance ,Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs), CBER,... human gene therapy chemistry manufacturing information for https://www.jnj.com/media-center/press-releases/data-published-in-the-lancet-shows-high-efficacy-at-96-weeks-for-first-investigational-two-drug-long-acting-injectable-hiv-regimen Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug,... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-04271&r=1 Investigational Scans for the Prediction of Genetic Mutations in Patients with Glioma, ReGIT Study... Investigational Scans for the Prediction of Genetic Mutations in Patients with Glioma, ReGIT Study https://www.biospace.com/xenoport-inc-submits-investigational-new-drug-application-for-xp23829-as-a-potential-treatment-of-rrms XenoPort, Inc. Submits Investigational New Drug Application for XP23829 as a Potential Treatment of... https://www.biospace.com/press-releases/acepodia-announces-fda-clearance-of-investigational-new-drug-application-for-ace1831-in-igg4-related-disease Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in... investigational new drug fda clearance https://www.businesswire.com/news/home/20241019252729/en/Gilead-and-Merck-Announce-Phase-2-Data-Showing-a-Treatment-Switch-to-an-Investigational-Oral-Once-Weekly-Combination-Regimen-of-Islatravir-and-Lenacapavir-Maintained-Viral-Suppression-in-Adults-at-Week-48 Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral... Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new results from a Phase 2 ... https://www.utsouthwestern.edu/research/orra/regulatory-support/si-support/ind.html Investigational New Drug (IND) - UT Southwestern An Investigational New Drug (IND) is a request for authorization from the Food and Drug Administration (FDA) to administer an investigational drug or... investigational new drug ind ut https://www.prnewswire.com/news-releases/fda-grants-breakthrough-therapy-designation-for-daiichi-sankyo-and-plexxikons-investigational-csf-1r-inhibitor-pexidartinib-plx3397-in-tenosynovial-giant-cell-tumor-300169556.html FDA Grants Breakthrough Therapy Designation for Daiichi Sankyo and Plexxikon's Investigational... /PRNewswire/ -- Daiichi Sankyo, Inc. and Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that the U.S. Food and Drug Administration... breakthrough therapy https://www.takeda.com/en-us/newsroom/news-releases/2010/new-head-to-head-phase-3-study-evaluated-systolic-blood-pressure-reduction-of-investigational-compound-azilsartan-medoxomil-compared-to-valsartan/ New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational... New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan phase 3 study systolic blood pressure https://www.jnj.com/media-center/press-releases/janssen-investigational-treatment-for-schizophrenia-shows-positive-efficacy-delays-relapse Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse Nov 30, 2025 - Independent Data Monitoring Committee Recommends Halting Trial and Unblinding Data Based on Treatment Efficacy investigational treatment janssen schizophrenia shows positive https://www.prnewswire.com/news-releases/mylan-to-supply-investigational-antiviral-remdesivir-for-the-potential-treatment-of-covid-19-301058044.html Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced, as part of its ongoing efforts to support patients and public health needs during the COVID-19... https://www.mdpi.com/1999-4915/17/6/793 Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus... Respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness in infants, young children, as well as elderly and immunocompromised... https://www.prnewswire.com/news-releases/nested-therapeutics-announces-fda-clearance-of-investigational-new-drug-ind-application-for-nst-628-a-novel-pan-rafmek-molecular-glue-302101827.html Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for... /PRNewswire/ -- Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today... investigational new drug fda clearance https://www.biospace.com/seres-therapeutics-announces-presentation-of-preliminary-pk-pd-and-safety-data-for-investigational-microbiome-therapeutic-ser-155-at-ash-2023 Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational... Dec 8, 2023 - Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that preliminary clinical data from a currently enrolling Phase 1b study of... https://www.biospace.com/nuvation-bio-announces-fda-clearance-of-investigational-new-drug-application-for-nuv-422-for-the-treatment-of-advanced-breast-cancer Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the... Dec 8, 2021 - Nuvation Bio Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate... https://pharmaceutical-journal.com/article/news/investigational-anti-clotting-drug-reduced-stroke-risk-by-more-than-one-quarter-study-finds Investigational anti-clotting drug reduced stroke risk by more than one-quarter, study finds - The... Apr 20, 2026 - The Pharmaceutical Journal from the Royal College of Pharmacy https://www.mdpi.com/2079-6382/11/9/1234 SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides... Clostridioides difficile infection (CDI) is classified as an urgent health threat by the Centers for Disease Control and Prevention (CDC), and affects nearly... ser 109 https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-receives-complete-response-letter-from-us-fda-for-use-of-investigational-cabotegravir-and-rilpivirine-long-acting-regimen-in-the-treatment-of-hiv/ ViiV Healthcare receives complete response letter from US FDA for use of investigational... ViiV Healthcare received a CRL from the FDA regarding its application for cabotegravir and rilpivirine. complete response letter https://www.prnewswire.com/news-releases/digital-submission-of-adverse-event-reports-for-investigational-new-drug-applications-reflects-fdas-ongoing-modernization-efforts-300947617.html Digital submission of adverse event reports for investigational new drug applications reflects... /PRNewswire/ -- The U.S. Food and Drug Administration is taking steps towards requiring electronic submission of certain safety reports for products being... adverse event reports investigational new drug https://www.gilead.com/news/news-details/2015/gilead-announces-phase-3-results-for-investigational-once-daily-single-tablet-hiv-regimen-containing-tenofovir-alafenamide-taf Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen... Gilead Announces Phase 3 Results for Investigational Once Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide TAF https://www.hhs.gov/guidance/document/investigational-ivds-used-clinical-investigations-therapeutic-products-draft-guidance Investigational IVDs Used in Clinical Investigations of Therapeutic Products: Draft Guidance for... used in clinical investigations https://www.utsouthwestern.edu/research/orra/regulatory-support/si-support/ide.html Investigational Device Exemption (IDE) - UT Southwestern An Investigational Device Exemption (IDE) is a regulatory submission that permits an investigational device to be used in a clinical study in order to collect... investigational device exemption ide ut https://www.mdanderson.org/cancerwise/how-our-investigational-pharmacy-services-team-gives-cancer-pati.h00-158989812.html How our Investigational Pharmacy Services team gives cancer patients hope | UT MD Anderson MD Anderson's Investigational Pharmacy Services team plays a crucial role in advancing clinical trials and cancer research, giving cancer patients hope and... https://www.biospace.com/immune-pharma-announces-fda-acceptance-of-investigational-new-drug-ind-application-in-the-u-s-for-bertilimumab-for-the-treatment-of-bullous-pemphig Immune Pharma Announces FDA Acceptance Of Investigational New Drug (IND) Application In The U.S.... https://www.fda.gov/drugs/investigational-new-drug-ind-application/investigational-new-drug-ind-and-emergency-investigational-new-drug-eind-application-information Investigational New Drug (IND) and Emergency Investigational New Drug (EIND) Application... Information for investigators about submitting Investigational New Drug (IND) applications to FDA investigational new drug ind emergency application https://www.biospace.com/merck-canada-announces-expansion-of-manufacturing-for-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-covid-19 Merck Canada Announces Expansion of Manufacturing for Molnupiravir, an Investigational Oral... Dec 6, 2021 - Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced today it has entered into an agreement with Thermo Fisher Scientific to... merck canada announces expansion https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-02316&r=1 Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or... Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma... safety and efficacy https://investingnews.com/new-clinical-and-preclinical-data-for-investigational-candidate-zidesamtinib-presented-at-aacr-annual-meeting-2026/ New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR... Apr 17, 2026 - Zidesamtinib demonstrated meaningful clinical activity in subset of TKI pre-treated ROS1-positive NSCLC patients from ARROS-1 trial previously treated with... preclinical data https://www.hmpgloballearningnetwork.com/site/eplab/feature-interview/new-investigational-concept-left-atrial-appendage-closure-stroke A New Investigational Concept in Left Atrial Appendage Closure for Stroke Prevention in Atrial... Atman P Shah, MD, FSCAI, FPICS, discusses current challenges in left atrial appendage closure (LAA) and shares insights into the early development of an... left atrial appendage closure https://www.businesswire.com/news/home/20230320005017/en/Aviceda-Announces-Successful-Submission-of-an-Investigational-New-Drug-IND-and-Fast-Track-Designation-FTD-Application-for-AVD-104-for-the-Treatment-of-Geographic-Atrophy-Associated-with-Age-Related-Macular-Degeneration-AMD Aviceda Announces Successful Submission of an Investigational New Drug (IND) and Fast Track... Aviceda Therapeutics, a private biotech company focused on developing the next generation immuno-modulators by harnessing the power of glycobiology to modula... investigational new drug https://www.biospace.com/astex-therapeutics-initiates-clinical-trial-with-investigational-anti-cancer-drug-at9283 Astex Therapeutics Initiates Clinical Trial With Investigational Anti-Cancer Drug AT9283 - BioSpace anti cancer drug astex therapeutics clinical trial https://www.merck.com/news/merck-provides-regulatory-update-on-investigational-medicine-sugammadex-injection/ Merck Provides Regulatory Update on Investigational Medicine Sugammadex Injection - Merck.com May 11, 2026 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, said it was informed today that the U.S. Food and Drug Administration (FDA) has cancelled... regulatory update merck provides investigational medicine https://www.biospace.com/press-releases/cure-rare-disease-receives-orphan-drug-designation-from-fda-for-investigational-therapy-targeting-spinocerebellar-ataxia-type-3-sca3 Cure Rare Disease Receives Orphan Drug Designation from FDA for Investigational Therapy Targeting... cure rare disease orphan drug designation https://www.prnewswire.com/news-releases/shires-shp626-volixibat-receives-fda-fast-track-designation-for-an-investigational-treatment-for-adults-who-have-nonalcoholic-steatohepatitis-nash-with-liver-fibrosis-588636781.html Shire's SHP626 (Volixibat) Receives FDA Fast Track Designation for an Investigational Treatment for... /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track... fda fast track https://www.cdc.gov/flu/hcp/testing-methods/guide-virus-diagnostic-tests.html Influenza virus testing in investigational outbreaks in institutional or other closed settings |... Flowchart: influenza virus testing for outbreaks in institutional or other closed settings. influenza virus testing investigational https://www.biospace.com/perosphere-inc-to-present-investigational-broad-spectrum-anticoagulant-reversal-agent-per977-data-at-american-college-of-cardiology-64th-annual-scient Perosphere Inc.To Present Investigational Broad-Spectrum Anticoagulant Reversal Agent PER977 Data... broad spectrum https://www.biospace.com/lexaria-provides-update-on-investigational-new-drug-application-progress Lexaria Provides Update on Investigational New Drug Application Progress - BioSpace Aug 30, 2023 - Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is providing this update on... investigational new drug provides update application progress https://www.biospace.com/press-releases/perre-fabre-pharmaceuticals-inc-announces-transfer-of-investigational-new-drug-application-for-tabelecleucel-from-atara-biotherapeutics-inc Perre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for... investigational new drug https://www.merck.com/news/aicuris-and-merck-enter-exclusive-worldwide-license-agreement-for-investigational-portfolio-targeting-human-cytomegalovirus/ AiCuris and Merck Enter Exclusive Worldwide License Agreement for Investigational Portfolio... Mar 22, 2023 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and AiCuris today announced that they have entered into an exclusive worldwide licensing... license agreement merck enter exclusive https://www.merck.com/news/merck-announces-fda-acceptance-of-new-drug-application-for-vorapaxar-investigational-anti-thrombotic-medicine/ Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational... Mar 22, 2023 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for its investigational... new drug application merck announces fda acceptance https://www.dict.cc/?s=non-investigational dict.cc | non-investigational | English Dictionary English Translation for non-investigational - dict.cc German-English Dictionary dict cc non investigational english dictionary https://everything2.com/user/bumpinfresh/writeups/Investigational%20New%20Drug%20Application Investigational New Drug Application (thing) An Investigational New Drug Application (IND) is a request for authorization from the U.S. Food and Drug Administration (FDA) to administer an... investigational new drug application thing https://www.citizen.org/article/comments-on-fda-proposal-on-access-to-and-charging-for-investigational-drugs/ Comments on FDA Proposal on Access to and Charging for Investigational Drugs - Public Citizen Jun 28, 2019 - Comments by Peter Lurie, M.D., M.P.H, Allison Zieve, J.D. and Sidney M. Wolfe, M.D. https://www.gilead.com/news/news-details/2007/gilead-announces-phase-i-data-for-gs-9190-an-investigational-compound-for-the-treatment-of-chronic-hepatitis-c Gilead Announces Phase I Data for GS 9190, An Investigational Compound for the Treatment of Chronic... Gilead Announces Phase I Data for GS 9190 An Investigational Compound for the Treatment of Chronic Hepatitis C https://www.news-medical.net/news/20260410/FDA-clears-investigational-new-drug-application-to-test-sCAR-T-therapy-for-autoimmune-conditions.aspx FDA clears investigational new drug application to test sCAR-T therapy for autoimmune conditions Apr 10, 2026 - Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their... https://www.globenewswire.com/news-release/2017/08/15/1152989/0/en/VBI-Vaccines-Announces-FDA-Acceptance-of-Investigational-New-Drug-Application-for-VBI-1901-to-Treat-Glioblastoma-Multiforme.html VBI Vaccines Announces FDA Acceptance of Investigational VBI-1901 is a novel immunotherapy developed using VBI's eVLP technologyOn track to initiate a Phase I/2a clinical study in the second half of 2017... vbi vaccines announces fda acceptance investigational https://www.mskcc.org/news-releases/new-phase-1-data-from-mskcc-shows-investigational-cancer-vaccine-may-elicit-lasting-immune-response-in-patients-with-pancreatic New Phase 1 Data from Memorial Sloan Kettering Cancer Center Shows an Investigational Cancer... New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the... sloan kettering cancer center https://www.merck.com/news/merck-provides-u-s-regulatory-update-on-investigational-ezetimibe-atorvastatin-tablets/ Merck Provides U.S. Regulatory Update on Investigational Ezetimibe/Atorvastatin Tablets - Merck.com Mar 8, 2021 - WHITEHOUSE STATION, N.J., March 5, 2012 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug... u s regulatory update https://www.news-medical.net/life-sciences/What-is-an-Investigational-New-Drug.aspx What is an Investigational New Drug? Mar 31, 2022 - The development of new, safe, and efficacious medications is subject to strict guidelines set out by international bodies and governments. what is investigational new drug https://www.brighamandwomens.org/patients-and-families/pharmacy/investigational-drug-services Investigational Drug Services Pharmacy - Brigham and Women's Hospital Find information about Investigational Drug Service pharmacy services and locations at Brigham and Women's Hospital. investigational drug services and women pharmacy brigham hospital https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/task-force-rosters Task Force Rosters - Investigational Drug Steering Committee - NCI Names and affiliations of members of the Investigational Drug Steering Committee Task Forces task force investigational drug steering committee rosters nci https://www.biospace.com/jazz-pharmaceuticals-to-present-data-on-defibrotide-an-investigational-treatment-in-patients-with-hepatic-veno-occlusive-disease-vod-at-bmt-tandem Jazz Pharmaceuticals To Present Data On Defibrotide, An Investigational Treatment, In Patients With... https://www.biospace.com/bristol-myers-squibb-announces-acceptance-of-new-drug-application-for-investigational-daclatasvir-for-fda-review-for-the-treatment-of-hepatitis-c-geno Bristol-Myers Squibb Announces Acceptance Of New Drug Application For Investigational Daclatasvir... bristol myers squibb new drug application https://www.merck.com/news/merck-to-present-new-data-on-investigational-chronic-hepatitis-c-treatment-elbasvir-grazoprevir-at-the-liver-meeting-2015-including-phase-3-results-in-selected-difficult-to-treat-populations/ Merck to Present New Data on Investigational Chronic Hepatitis C Treatment Elbasvir/Grazoprevir at... May 11, 2026 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data from clinical trials of its investigational treatment... https://www.citizen.org/article/summary-on-proposed-investigational-device-medical-exemption-regulations/ Summary on Proposed Investigational Device (Medical) Exemption Regulations - Public Citizen summary proposed investigational device medical https://www.biospace.com/biotheryx-announces-u-s-fda-clearance-of-investigational-new-drug-application-for-btx-9341-a-first-in-class-dual-bifunctional-degrader-of-cdk4-6 Biotheryx Announces U.S. FDA Clearance of Investigational New Drug Application for BTX-9341, a... May 8, 2024 - Biotheryx, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for... https://www.businesswire.com/news/home/20210113005177/en/UroGen-Pharma-and-MD-Anderson-Announce-Strategic-Research-Collaboration-to-Advance-Investigational-Treatment-for-High-Grade-Bladder-Cancer UroGen Pharma and MD Anderson Announce Strategic Research Collaboration to Advance Investigational... UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and uro... md anderson https://www.uchicagomedicine.org/forefront/news/investigational-drug-shows-promise-in-kidney-cancer-patients Investigational drug shows promise in kidney cancer patients - UChicago Medicine investigational drug kidney cancer shows promise patients https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-04271 Investigational Scans for the Prediction of Genetic Mutations in Patients with Glioma, ReGIT Study... Investigational Scans for the Prediction of Genetic Mutations in Patients with Glioma, ReGIT Study https://www.biospace.com/b-virginia-commonwealth-university-medical-center-b-seeks-heart-failure-patients-for-investigational-study-evaluating-use-of-new-implantable-pulse Virginia Commonwealth University Medical Center Seeks Heart Failure Patients For Investigational... university medical center heart failure patients virginia commonwealth https://www.prnewswire.co.uk/news-releases/johnson-amp-johnson-announces-agreement-with-u-s-government-for-100-million-doses-of-investigational-covid-19-vaccine-843714986.html Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational... u s government https://www.mdedge.com/content/investigational-antibiotic-mrsa-found-effective-safe Investigational Antibiotic for MRSA Found Effective, Safe | MDedge investigational antibiotic mrsa found effective https://www.biospace.com/apnimed-to-present-positive-phase-2b-results-on-ad109-an-investigational-oral-treatment-for-obstructive-sleep-apnea-at-ats-2023 Apnimed to Present Positive Phase 2b Results on AD109, an Investigational Oral Treatment for... May 15, 2023 - Apnimed announced that data from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study of one-month duration, will be featured in both an... https://www.businesswire.com/news/home/20231010850022/en/Interim-Results-from-a-NanOlogy-Phase-2-Clinical-Trial-of-its-Intratumoral-Investigational-Drug-in-the-Treatment-of-Locally-Advanced-Pancreatic-Cancer Interim Results from a NanOlogy Phase 2 Clinical Trial of its Intratumoral Investigational Drug in... Research article published in Pancreas Journal reports initial safety and clinical outcome data from a Phase 2a clinical trial of IT LSAM-PTX in LAPC. https://www.uchicagomedicine.org/forefront/news/investigational-drug-may-protect-cancer-and-aids-patients-from-side-effects-of-pain-relief-therapy Investigational drug may protect cancer and AIDS patients from side effects of pain relief therapy... https://www.biospace.com/press-releases/intellia-presents-positive-results-from-the-phase-2-study-of-ntla-2002-an-investigational-in-vivo-crispr-gene-editing-treatment-for-hereditary-angioedema-hae Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo... https://www.biospace.com/pfizer-announces-positive-top-line-results-from-second-pivotal-phase-3-study-of-investigational-oral-jak1-candidate-abrocitinib-in-patients-aged-12-and-older-with-moderate-to-severe-atopic-dermatitis Pfizer Announces Positive Top-Line Results from Second Pivotal Phase 3 Study of Investigational... Sep 27, 2019 - Pfizer Inc. announced positive top-line results from a second Phase 3 pivotal study evaluating the efficacy and safety of its investigational oral Janus kinase... https://www.merck.com/news/merck-announces-topline-results-from-phase-2b-3-trial-of-clesrovimab-mk-1654-an-investigational-respiratory-syncytial-virus-preventative-monoclonal-antibody-for-infants/ Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational... Dec 31, 2025 - Clesrovimab met all primary safety and efficacy endpoints Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive...